Cargando…

Antiviral Immunity and Prophylaxis

This chapter argues that antiviral immunity in animals is mediated by both cellular and humoral factors, and the nature of the immune response generated by different individuals infected with the same virus can be different, depending on the individual's genetic constitution, environmental infl...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150302/
http://dx.doi.org/10.1016/B978-0-12-375158-4.00004-3
_version_ 1783520999033012224
collection PubMed
description This chapter argues that antiviral immunity in animals is mediated by both cellular and humoral factors, and the nature of the immune response generated by different individuals infected with the same virus can be different, depending on the individual's genetic constitution, environmental influences, and other factors that can determine the course and pathogenesis of the infection. Innate immune defenses exhibit neither antigen specificity nor memory, but they provide a critical line of first defense against viral infections because they are constantly present and are operational immediately after viral infection. Innate immunity is often considered separate from acquired immune responses, but they are inextricably linked, and innate responses modulate subsequent acquired responses in many ways. Viruses that are transmitted horizontally between individuals must first breach the barriers at their portal of entry before they can cause infection in their respective hosts. In the ongoing war and détente between virus and host, viruses have developed remarkably sophisticated mechanisms to avoid the various host protective responses. Vaccination is the most effective way of preventing viral diseases. There are some important differences between vaccination practices in humans and animals. The immunogenicity of inactivated vaccines, especially that of purified protein vaccines and synthetic peptides, usually needs to be enhanced; this may be achieved by mixing the antigen with an adjuvant, incorporation of the antigen in liposomes, or incorporation of the antigen in an immunostimulating complex.
format Online
Article
Text
id pubmed-7150302
institution National Center for Biotechnology Information
language English
publishDate 2011
record_format MEDLINE/PubMed
spelling pubmed-71503022020-04-13 Antiviral Immunity and Prophylaxis Fenner's Veterinary Virology Article This chapter argues that antiviral immunity in animals is mediated by both cellular and humoral factors, and the nature of the immune response generated by different individuals infected with the same virus can be different, depending on the individual's genetic constitution, environmental influences, and other factors that can determine the course and pathogenesis of the infection. Innate immune defenses exhibit neither antigen specificity nor memory, but they provide a critical line of first defense against viral infections because they are constantly present and are operational immediately after viral infection. Innate immunity is often considered separate from acquired immune responses, but they are inextricably linked, and innate responses modulate subsequent acquired responses in many ways. Viruses that are transmitted horizontally between individuals must first breach the barriers at their portal of entry before they can cause infection in their respective hosts. In the ongoing war and détente between virus and host, viruses have developed remarkably sophisticated mechanisms to avoid the various host protective responses. Vaccination is the most effective way of preventing viral diseases. There are some important differences between vaccination practices in humans and animals. The immunogenicity of inactivated vaccines, especially that of purified protein vaccines and synthetic peptides, usually needs to be enhanced; this may be achieved by mixing the antigen with an adjuvant, incorporation of the antigen in liposomes, or incorporation of the antigen in an immunostimulating complex. 2011 2010-11-11 /pmc/articles/PMC7150302/ http://dx.doi.org/10.1016/B978-0-12-375158-4.00004-3 Text en Copyright © 2011 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Antiviral Immunity and Prophylaxis
title Antiviral Immunity and Prophylaxis
title_full Antiviral Immunity and Prophylaxis
title_fullStr Antiviral Immunity and Prophylaxis
title_full_unstemmed Antiviral Immunity and Prophylaxis
title_short Antiviral Immunity and Prophylaxis
title_sort antiviral immunity and prophylaxis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150302/
http://dx.doi.org/10.1016/B978-0-12-375158-4.00004-3